resveratrol has been researched along with Bone Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiou, YS; Ho, CT; Lee, PS; Pan, MH | 1 |
| Chen, KM; Howe, PR; King, TJ; Lee, AM; Shandala, T; Soo, PP; Su, YW; Xian, CJ | 1 |
1 review(s) available for resveratrol and Bone Diseases
| Article | Year |
|---|---|
Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation.
Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Bone Diseases; Cardiovascular Diseases; Chemoprevention; DNA Methylation; Epigenesis, Genetic; Histones; Humans; MicroRNAs; Neoplasms; Neurodegenerative Diseases; Protein Processing, Post-Translational; Resveratrol; Stilbenes | 2018 |
1 other study(ies) available for resveratrol and Bone Diseases
| Article | Year |
|---|---|
Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss.
Topics: Adipocytes; Adipogenesis; Animals; Bone and Bones; Bone Diseases; Dietary Supplements; Dose-Response Relationship, Drug; Male; Methotrexate; Osteoclasts; Osteogenesis; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2017 |